Valuation dashboard for Abivax S.A. (ABVX) with P/E N/A, P/B 15.11, EV/EBITDA -24.97 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
Abivax S.A., operating as ABIVAX Société Anonyme, is a French pharmaceutical firm focused on the discovery and optimization of therapeutic drugs for inflammatory, infectious, and oncological diseases. A cornerstone of their product pipeline is ABX464, which is currently undergoing Phase IIb clinical trials for ulcerative colitis, Crohn's Disease, and COVID-19.
Analysis Summary
Trailing-twelve-month margins: gross margin 0.0%, operating margin 0.0%, net margin 0.0%.
At the current price of $106.38, ABVX has negative trailing earnings (P/E not meaningful) and an ROE of -73.87%. Market capitalisation stands at $7.8B.
Balance sheet quality for ABVX: current ratio of 8.7. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 15.11 |
| EV / EBITDA | -24.97 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $7.44 |
| vs Current Price | -93.0% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ABVX | Abivax S.A. | $7.5B | 15.11 | -73.9% | |
| JAZZ | Jazz Pharmaceuticals plc | $15.5B | 15.84 | 3.17 | 21.4% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.2B | 29.72 | -56.6% | |
| AXSM | Axsome Therapeutics, Inc. | $10.9B | |||
| HALO | Halozyme Therapeutics, Inc. | $12.7B | 30.18 | 86.81 | |
| CYTK | Cytokinetics, Incorporated | $9.1B | 119.0% | ||
| CORT | Corcept Therapeutics Incorporated | $12.1B | 207.35 | 16.10 | 8.4% |
Price
| Price | $106.38 |
| Market Cap | $7.8B |
| Exchange | NASDAQ |
| Country | FR |
Profitability
| Return on Equity | -73.87% |
| Return on Invested Capital | -44.70% |
| Return on Assets | -57.54% |
| Gross Margin | 0.00% |
| Operating Margin | 0.00% |
| Net Margin | 0.00% |
Related companies: AXSM · CORT · CYTK · HALO · JAZZ · MDGL · MRUS
Explore sector: Healthcare · Biotechnology
More sections of ABVX: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks